uric acid has been researched along with Vascular Diseases in 72 studies
Uric Acid: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN.
uric acid : An oxopurine that is the final oxidation product of purine metabolism.
6-hydroxy-1H-purine-2,8(7H,9H)-dione : A tautomer of uric acid having oxo groups at C-2 and C-8 and a hydroxy group at C-6.
7,9-dihydro-1H-purine-2,6,8(3H)-trione : An oxopurine in which the purine ring is substituted by oxo groups at positions 2, 6, and 8.
Vascular Diseases: Pathological processes involving any of the BLOOD VESSELS in the cardiac or peripheral circulation. They include diseases of ARTERIES; VEINS; and rest of the vasculature system in the body.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Over the last decade, the biologic interference of uric acid with the cardiovascular (CV) system and the kidney has been intensively investigated, and several experimental studies in animal models and in vitro documented that hyperuricemia may trigger hypertension and incite endothelial dysfunction, vascular damage and renal disease." | 8.89 | Uric acid, hypertension, and cardiovascular and renal complications. ( Mallamaci, F; Zoccali, C, 2013) |
| "Serum uric acid (SUA) level is known to have a prognostic value in patients with acute coronary syndrome (ACS)." | 7.91 | Relation of Elevated Serum Uric Acid Level to Endothelial Dysfunction in Patients with Acute Coronary Syndrome. ( Fujimoto, Y; Kitahara, H; Kobayashi, Y; Nakayama, T; Saito, Y, 2019) |
| " Uric acid is also associated with endothelial dysfunction, oxidative stress, and CVD, raising the hypothesis that an increased serum uric acid might predict ED in patients who are at risk for coronary artery disease (CAD)." | 7.80 | Uric acid level and erectile dysfunction in patients with coronary artery disease. ( Akilli, H; Aribas, A; Covic, A; Gaipov, A; Johnson, RJ; Kanbay, M; Kayrak, M; McFann, K; Perez-Pozo, SE; Solak, Y; Turk, S, 2014) |
| "Serum uric acid (UA) is now beginning to be considered a risk predictor for cardiovascular diseases." | 7.80 | Serum uric acid as a risk predictor for erectile dysfunction. ( Heydari, R; Mehrsai, A; Pourmand, G; Salem, S, 2014) |
| "Plasma fibrinogen content was measured in 20 normal subjects, 20 patients with diabetes mellitus, 20 patients with hyperlipoproteinemia type II or IV (Fredrickson) and 10 patients with hyperuricemia." | 7.65 | [Plasma fibrinogen activity in diabetes mellitus, hyperlipoproteinemia and hyperuricemia (author's transl)]. ( Gross, W; Zöller, H, 1976) |
| "Uric acid is a major product of purine metabolism in humans." | 6.46 | Uric acid and the development of hypertension. ( Hwu, CM; Lin, KH, 2010) |
| "Over the last decade, the biologic interference of uric acid with the cardiovascular (CV) system and the kidney has been intensively investigated, and several experimental studies in animal models and in vitro documented that hyperuricemia may trigger hypertension and incite endothelial dysfunction, vascular damage and renal disease." | 4.89 | Uric acid, hypertension, and cardiovascular and renal complications. ( Mallamaci, F; Zoccali, C, 2013) |
| "Although uric acid is considered an antioxidant in plasma, recent clinical and epidemiological studies have found that hyperuricemia is associated with mortality and development of hypertension, cardiovascular and chronic renal diseases." | 4.83 | Hormonal and cytokine effects of uric acid. ( Feig, DI; Franco, M; Herrera-Acosta, J; Johnson, RJ; Kang, DH; Nakagawa, T; Sánchez-Lozada, LG, 2006) |
| "Serum uric acid (SUA) level is known to have a prognostic value in patients with acute coronary syndrome (ACS)." | 3.91 | Relation of Elevated Serum Uric Acid Level to Endothelial Dysfunction in Patients with Acute Coronary Syndrome. ( Fujimoto, Y; Kitahara, H; Kobayashi, Y; Nakayama, T; Saito, Y, 2019) |
| " One-hundred and seventy-eight CKD patients with hyperuricemia who received febuxostat therapy were included in this study." | 3.85 | Identification of chronic kidney disease patient characteristics influencing the renoprotective effects of febuxostat therapy: a retrospective follow-up study. ( Harada, M; Hashimoto, K; Kamijo, Y; Yamada, Y; Yamaguchi, A, 2017) |
| " Uric acid is also associated with endothelial dysfunction, oxidative stress, and CVD, raising the hypothesis that an increased serum uric acid might predict ED in patients who are at risk for coronary artery disease (CAD)." | 3.80 | Uric acid level and erectile dysfunction in patients with coronary artery disease. ( Akilli, H; Aribas, A; Covic, A; Gaipov, A; Johnson, RJ; Kanbay, M; Kayrak, M; McFann, K; Perez-Pozo, SE; Solak, Y; Turk, S, 2014) |
| " Treating asymptomatic hyperuricemia with urate-lowering drugs such as allopurinol may reduce CV events." | 3.80 | Treatment of asymptomatic hyperuricemia and prevention of vascular disease: a decision analytic approach. ( Akkineni, R; Albert, DA; Choi, HK; Lee, A; Miller, KL; Tapp, S; Tosteson, AN; Zhu, Y, 2014) |
| "Serum uric acid (UA) is now beginning to be considered a risk predictor for cardiovascular diseases." | 3.80 | Serum uric acid as a risk predictor for erectile dysfunction. ( Heydari, R; Mehrsai, A; Pourmand, G; Salem, S, 2014) |
| "Plasma fibrinogen content was measured in 20 normal subjects, 20 patients with diabetes mellitus, 20 patients with hyperlipoproteinemia type II or IV (Fredrickson) and 10 patients with hyperuricemia." | 3.65 | [Plasma fibrinogen activity in diabetes mellitus, hyperlipoproteinemia and hyperuricemia (author's transl)]. ( Gross, W; Zöller, H, 1976) |
| "Uric acid is a major product of purine metabolism in humans." | 2.46 | Uric acid and the development of hypertension. ( Hwu, CM; Lin, KH, 2010) |
| "Uric acid has previously been viewed as a benign solute in serum until it exceeds its saturation level." | 2.45 | The role of hyperuricemia in vascular disorders. ( Edwards, NL, 2009) |
| "Uric acid was associated negatively with FMD% in an age- and gender-adjusted model, while not in the multivariable model." | 1.40 | Uric acid and clinical correlates of endothelial function in kidney transplant recipients. ( Asberg, A; Dahle, DO; Dörje, C; Eide, IA; Halden, TA; Hartmann, A; Holdaas, H; Holme, I; Jenssen, T; Mjøen, G; Pihlstrøm, H; Soveri, I, 2014) |
| "Cardiovascular diseases are the leading cause of death for both women and men." | 1.40 | [Gender and subclinical vascular organ damage in patients with coronary artery disease and/or hypertension]. ( Lucyna, WL; Posadzy-Małaczyńska, A, 2014) |
| "Hyperuricemia is associated with renal disease, but it is usually considered a marker of renal dysfunction rather than a risk factor for progression." | 1.31 | A role for uric acid in the progression of renal disease. ( Feng, L; Han, L; Harris, R; Johnson, RJ; Kang, DH; Mazzali, M; Nakagawa, T; Truong, L; Watanabe, S, 2002) |
| "Hydrochlorothiazide treatment did not prevent the hyperuricemia or arteriolopathy despite controlling blood pressure." | 1.31 | Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism. ( Chen, Q; Feng, L; Gordon, KL; Han, L; Johnson, RJ; Kanellis, J; Kang, DH; Lan, HY; Mazzali, M; Nakagawa, T; Watanabe, S; Xia, YY, 2002) |
| "Analysis of 29 kindred showed hyperlipidemia in half of adult blood relatives; half of these had type III, the remainder usually had sample endogenous hyperglyceridemia (type IV)." | 1.25 | The biochemical, clinical, and genetic features of type III hyperlipoproteinemia. ( Fredrickson, DS; Levy, RI; Morganroth, J, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 37 (51.39) | 18.7374 |
| 1990's | 1 (1.39) | 18.2507 |
| 2000's | 11 (15.28) | 29.6817 |
| 2010's | 18 (25.00) | 24.3611 |
| 2020's | 5 (6.94) | 2.80 |
| Authors | Studies |
|---|---|
| Hayfron-Benjamin, CF | 1 |
| van den Born, BJ | 1 |
| Amoah, AGB | 1 |
| Maitland-van der Zee, AH | 1 |
| Meeks, KAC | 1 |
| Beune, EJAJ | 1 |
| Klipstein-Grobusch, K | 1 |
| Agyemang, C | 1 |
| Liu, P | 1 |
| Yin, C | 1 |
| Liu, M | 1 |
| Chang, L | 1 |
| Wu, T | 1 |
| Li, Z | 1 |
| Luo, R | 1 |
| Du, X | 1 |
| Zhao, W | 1 |
| Nata, N | 1 |
| Ninwisut, N | 1 |
| Inkong, P | 1 |
| Supasyndh, O | 1 |
| Satirapoj, B | 1 |
| Dong, W | 1 |
| Zhang, S | 1 |
| Yan, S | 1 |
| Zhao, Z | 1 |
| Zhang, Z | 1 |
| Gu, W | 1 |
| Harada, M | 2 |
| Fujii, K | 1 |
| Yamada, Y | 2 |
| Tsukada, W | 1 |
| Tsukada, M | 1 |
| Hashimoto, K | 2 |
| Kamijo, Y | 2 |
| Yamaguchi, A | 1 |
| Cicero, AFG | 1 |
| Caliceti, C | 1 |
| Fogacci, F | 1 |
| Giovannini, M | 1 |
| Calabria, D | 1 |
| Colletti, A | 1 |
| Veronesi, M | 1 |
| Roda, A | 1 |
| Borghi, C | 1 |
| Liu, H | 1 |
| Liu, J | 1 |
| Zhao, H | 1 |
| Zhou, Y | 1 |
| Li, L | 1 |
| Wang, H | 2 |
| Saito, Y | 1 |
| Kitahara, H | 1 |
| Nakayama, T | 1 |
| Fujimoto, Y | 1 |
| Kobayashi, Y | 1 |
| Zoccali, C | 2 |
| Mallamaci, F | 2 |
| Solak, Y | 1 |
| Akilli, H | 1 |
| Kayrak, M | 1 |
| Aribas, A | 1 |
| Gaipov, A | 1 |
| Turk, S | 1 |
| Perez-Pozo, SE | 1 |
| Covic, A | 2 |
| McFann, K | 1 |
| Johnson, RJ | 5 |
| Kanbay, M | 2 |
| Akkineni, R | 1 |
| Tapp, S | 1 |
| Tosteson, AN | 1 |
| Lee, A | 1 |
| Miller, KL | 1 |
| Choi, HK | 1 |
| Zhu, Y | 1 |
| Albert, DA | 1 |
| Salem, S | 1 |
| Mehrsai, A | 2 |
| Heydari, R | 1 |
| Pourmand, G | 2 |
| Dahle, DO | 1 |
| Jenssen, T | 1 |
| Holdaas, H | 1 |
| Asberg, A | 1 |
| Soveri, I | 1 |
| Holme, I | 1 |
| Mjøen, G | 1 |
| Eide, IA | 1 |
| Pihlstrøm, H | 1 |
| Dörje, C | 1 |
| Halden, TA | 1 |
| Hartmann, A | 1 |
| Lucyna, WL | 1 |
| Posadzy-Małaczyńska, A | 1 |
| Katsiki, N | 1 |
| Mikhailidis, DP | 2 |
| Gigante, A | 1 |
| Barbano, B | 1 |
| Barilaro, G | 1 |
| Quarta, S | 1 |
| Gasperini, ML | 1 |
| Di Mario, F | 1 |
| Romaniello, A | 1 |
| Amoroso, A | 1 |
| Cianci, R | 1 |
| Rosato, E | 1 |
| Salavati, A | 1 |
| Allameh, F | 1 |
| Alizadeh, F | 1 |
| Namdari, F | 1 |
| Hosseinian, M | 1 |
| Salimi, E | 1 |
| Heidari, F | 1 |
| Bo, S | 1 |
| Gambino, R | 1 |
| Durazzo, M | 1 |
| Ghione, F | 1 |
| Musso, G | 1 |
| Gentile, L | 1 |
| Cassader, M | 1 |
| Cavallo-Perin, P | 1 |
| Pagano, G | 1 |
| Edwards, NL | 1 |
| George, J | 1 |
| Struthers, AD | 1 |
| Wiernsperger, N | 1 |
| Geloen, A | 1 |
| Rapin, JR | 1 |
| Hwu, CM | 1 |
| Lin, KH | 1 |
| Yilmaz, MI | 1 |
| Sonmez, A | 1 |
| Turgut, F | 1 |
| Saglam, M | 1 |
| Cakir, E | 1 |
| Yenicesu, M | 1 |
| Jalal, D | 1 |
| Jin, M | 1 |
| Yang, F | 1 |
| Yang, I | 1 |
| Yin, Y | 1 |
| Luo, JJ | 1 |
| Yang, XF | 1 |
| Kang, DH | 4 |
| Nakagawa, T | 3 |
| Feng, L | 2 |
| Watanabe, S | 2 |
| Han, L | 2 |
| Mazzali, M | 2 |
| Truong, L | 1 |
| Harris, R | 1 |
| KRAMER, DW | 1 |
| PERILSTEIN, PK | 1 |
| DE MEDEIROS, A | 1 |
| GRIEBLE, HG | 1 |
| JOHNSTON, LC | 1 |
| FULLER, JB | 1 |
| KOELBEL, F | 1 |
| Daskalopoulou, SS | 1 |
| Athyros, VG | 1 |
| Elisaf, M | 1 |
| Kanellis, J | 2 |
| Sánchez-Lozada, LG | 1 |
| Feig, DI | 1 |
| Franco, M | 1 |
| Herrera-Acosta, J | 1 |
| Maio, R | 1 |
| Sesti, G | 1 |
| Perticone, F | 1 |
| Hamed, SA | 1 |
| Hamed, EA | 1 |
| Hamdy, R | 1 |
| Nabeshima, T | 1 |
| Jindal, S | 1 |
| Singh, M | 1 |
| Balakumar, P | 1 |
| Rapado, A | 1 |
| Marigo, S | 1 |
| Motti, C | 1 |
| Gnasso, A | 1 |
| Bernardini, S | 1 |
| Massoud, R | 1 |
| Pastore, A | 1 |
| Rampa, P | 1 |
| Federici, G | 1 |
| Cortese, C | 1 |
| Xia, YY | 1 |
| Chen, Q | 1 |
| Gordon, KL | 1 |
| Lan, HY | 1 |
| Morganroth, J | 1 |
| Levy, RI | 1 |
| Fredrickson, DS | 1 |
| Zöller, H | 1 |
| Gross, W | 1 |
| Mensen, H | 1 |
| Ballantyne, D | 1 |
| Strevens, EA | 1 |
| Lawrie, TD | 1 |
| Emmerson, BT | 1 |
| Medalie, JH | 2 |
| Papier, CM | 1 |
| Goldbourt, U | 2 |
| Herman, JB | 2 |
| Chait, A | 1 |
| Mancini, M | 1 |
| February, AW | 1 |
| Lewis, B | 1 |
| Müller-Schweinitzer, E | 1 |
| Eisenberg, S | 1 |
| Kwiterovich, PO | 1 |
| Margolis, S | 1 |
| Sirtori, CR | 1 |
| Biasi, G | 1 |
| Vercellio, G | 1 |
| Agradi, E | 1 |
| Malan, E | 1 |
| Feldman, EB | 1 |
| Gluck, FB | 1 |
| Carter, AC | 1 |
| Diamond, HS | 1 |
| Wellmann, KF | 1 |
| Volk, BW | 1 |
| Johnson, ES | 1 |
| Buchanan, KD | 1 |
| Bluhm, GB | 1 |
| Riddle, JM | 1 |
| Angelino, PF | 1 |
| Amati, L | 1 |
| Dulbecco, A | 1 |
| Curri, SB | 1 |
| Tiso, B | 1 |
| Herrlein, A | 1 |
| Papier, C | 1 |
| Tamir, S | 1 |
| Neufeld, HN | 1 |
| Riss, E | 1 |
| Notelovitz, M | 1 |
| Schneider, V | 1 |
| Thiele, P | 1 |
| Tellkamp, F | 1 |
| Heidelmann, G | 1 |
| Nolph, KD | 1 |
| Stoltz, ML | 1 |
| Maher, JF | 1 |
| Cammeo, F | 1 |
| Bourde, C | 1 |
| Bossa, G | 1 |
| Giordano, M | 1 |
| D'Onofrio, F | 1 |
| Grahame, R | 1 |
| Scott, JT | 1 |
| Tägert, J | 1 |
| Knappe, J | 1 |
| Knappe, G | 1 |
| Strube, G | 1 |
| Dück, KD | 1 |
| Relke, W | 1 |
| Borrie, P | 1 |
| Jouve, A | 1 |
| Avril, P | 1 |
| Rouvier, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Study on the Effect of Hyperuricaemia on Chronic Renal Disease and Intervention[NCT03425708] | Phase 4 | 400 participants (Anticipated) | Interventional | 2017-01-01 | Recruiting | ||
| The Effect of Allopurinol on Malondialdehyde, Nitric Oxide, Kidney Injury Molecule-1 Urine Levels, Resistive Index and Renal Elastography in Kidney Stone Patients After Extra Corporeal Shockwave Lithotripsy[NCT05414669] | Phase 4 | 35 participants (Actual) | Interventional | 2020-08-06 | Completed | ||
| Value of Uric Acid as Early Predictor of Lupus Nephritis in Assiut University Hospital[NCT05402735] | 100 participants (Anticipated) | Observational | 2022-06-15 | Recruiting | |||
| Study Protocol for a Prospective Observational Study Investigating the Role of Luminal Pressure on Arteriovenous Fistula Maturation[NCT04017806] | 60 participants (Anticipated) | Observational | 2018-09-19 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
12 reviews available for uric acid and Vascular Diseases
| Article | Year |
|---|---|
Uric acid, hypertension, and cardiovascular and renal complications.
Topics: Animals; Disease Models, Animal; Humans; Hypertension; Hyperuricemia; Kidney Diseases; Uric Acid; Va | 2013 |
Emerging Vascular Risk Factors in Women: Any Differences from Men?
Topics: Adult; Biomarkers; Female; Humans; Inflammation; Male; Periodontitis; Risk Factors; Sex Factors; Uri | 2015 |
The role of hyperuricemia in vascular disorders.
Topics: Animals; Biological Evolution; Cardiovascular Diseases; Disease Models, Animal; Humans; Hypertension | 2009 |
Role of urate, xanthine oxidase and the effects of allopurinol in vascular oxidative stress.
Topics: Allopurinol; Animals; Antioxidants; Endothelium, Vascular; Enzyme Inhibitors; Humans; Myocardium; Ox | 2009 |
Fructose and cardiometabolic disorders: the controversy will, and must, continue.
Topics: Diet; Fructose; Humans; Hypertriglyceridemia; Liver; Metabolic Syndrome; Risk Factors; Sweetening Ag | 2010 |
Uric acid and the development of hypertension.
Topics: Animals; Cross-Sectional Studies; Humans; Hypertension; Hyperuricemia; Insulin Resistance; Kidney; R | 2010 |
Uric acid, hyperuricemia and vascular diseases.
Topics: Coronary Disease; Gout; Humans; Hypertension; Hyperuricemia; Inflammasomes; Inflammation; Metabolic | 2012 |
[HYPERURICEMIA AND ITS CLINICAL SIGNIFICANCE].
Topics: Blood Chemical Analysis; Carbon Isotopes; Coronary Disease; Humans; Hypertension; Hyperuricemia; Kid | 1963 |
Uric acid as a mediator of endothelial dysfunction, inflammation, and vascular disease.
Topics: Animals; Arteries; Biomarkers; Disease Progression; Endothelium, Vascular; Humans; Hyperuricemia; Ur | 2005 |
Hormonal and cytokine effects of uric acid.
Topics: Antioxidants; Humans; Hyperuricemia; Muscle, Smooth, Vascular; Uric Acid; Vascular Diseases | 2006 |
Type IV hyperlipoproteinaemia.
Topics: Child; Cholesterol; Chylomicrons; Clofibrate; Diagnosis, Differential; Diet Therapy; Dietary Carbohy | 1973 |
Diabetes mellitus and gout.
Topics: Benzothiadiazines; Blood Glucose; Carbohydrate Metabolism; Diabetes Complications; Diabetes Mellitus | 1972 |
2 trials available for uric acid and Vascular Diseases
| Article | Year |
|---|---|
Effects of febuxostat on markers of endothelial dysfunction and renal progression in patients with chronic kidney disease.
Topics: C-Reactive Protein; Febuxostat; Humans; Hyperuricemia; Kidney; Renal Insufficiency, Chronic; Uric Ac | 2023 |
Effect of apple polyphenols on vascular oxidative stress and endothelium function: a translational study.
Topics: Antioxidants; Blood Glucose; Body Mass Index; Cells, Cultured; Dietary Supplements; Double-Blind Met | 2017 |
58 other studies available for uric acid and Vascular Diseases
| Article | Year |
|---|---|
Associations of Serum Uric Acid Levels With Macrovascular and Renal Microvascular Dysfunction Among Individuals From Sub-Saharan Africa.
Topics: Adult; Aged; Body Mass Index; Correlation of Data; Cross-Sectional Studies; Female; Ghana; Humans; M | 2021 |
Correlation between 24-Hour Ambulatory Blood Pressure Variability and White Matter Lesions in Patients with Cerebral Small Vascular Disease: A Cross-Sectional Study.
Topics: Blood Pressure; Blood Pressure Monitoring, Ambulatory; Cerebrovascular Disorders; Cross-Sectional St | 2022 |
Clinical characteristics of patients with early-onset diabetes mellitus: a single-center retrospective study.
Topics: Adolescent; Adult; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Ketosis; Male; Re | 2023 |
Relationship between serum uric acid level and vascular injury markers in hemodialysis patients.
Topics: Aged; Biomarkers; Cross-Sectional Studies; Endothelium, Vascular; Female; Humans; Male; Middle Aged; | 2020 |
Identification of chronic kidney disease patient characteristics influencing the renoprotective effects of febuxostat therapy: a retrospective follow-up study.
Topics: Adolescent; Adult; Age Distribution; Aged; Aged, 80 and over; Comorbidity; Febuxostat; Female; Follo | 2017 |
Relationship between Serum Uric Acid and Vascular Function and Structure Markers and Gender Difference in a Real-World Population of China-From Beijing Vascular Disease Patients Evaluation Study (BEST) Study.
Topics: Aged; Ankle Brachial Index; Beijing; Biomarkers; Blood Pressure; Body Mass Index; Carotid Intima-Med | 2018 |
Relation of Elevated Serum Uric Acid Level to Endothelial Dysfunction in Patients with Acute Coronary Syndrome.
Topics: Acute Coronary Syndrome; Aged; Biomarkers; Endothelium, Vascular; Female; Follow-Up Studies; Humans; | 2019 |
Uric acid level and erectile dysfunction in patients with coronary artery disease.
Topics: Aged; C-Reactive Protein; Coronary Artery Disease; Cross-Sectional Studies; Diabetes Mellitus; Erect | 2014 |
Treatment of asymptomatic hyperuricemia and prevention of vascular disease: a decision analytic approach.
Topics: Aged; Allopurinol; Decision Support Techniques; Female; Follow-Up Studies; Gout Suppressants; Humans | 2014 |
Serum uric acid as a risk predictor for erectile dysfunction.
Topics: Biomarkers; Cardiovascular Diseases; Case-Control Studies; Confidence Intervals; Erectile Dysfunctio | 2014 |
Uric acid and clinical correlates of endothelial function in kidney transplant recipients.
Topics: Cross-Sectional Studies; Endothelium, Vascular; Female; Follow-Up Studies; Glomerular Filtration Rat | 2014 |
[Gender and subclinical vascular organ damage in patients with coronary artery disease and/or hypertension].
Topics: Ankle Brachial Index; Carotid Intima-Media Thickness; Comorbidity; Coronary Disease; Female; Hemodyn | 2014 |
Serum uric acid as a marker of microvascular damage in systemic sclerosis patients.
Topics: Adult; Arterial Pressure; Biomarkers; Creatinine; Echocardiography; Female; Humans; Male; Microcircu | 2016 |
Is Serum Uric Acid Level Correlated with Erectile Dysfunction in Coronary Artery Disease Patients?
Topics: Adult; Case-Control Studies; Coronary Angiography; Coronary Artery Disease; Erectile Dysfunction; Fe | 2016 |
Associations between serum uric acid and adipokines, markers of inflammation, and endothelial dysfunction.
Topics: Adipokines; Biomarkers; Cross-Sectional Studies; Endothelium, Vascular; Humans; Inflammation; Inflam | 2008 |
Serum uric acid level and endothelial dysfunction in patients with nondiabetic chronic kidney disease.
Topics: Adult; Blood Pressure; C-Reactive Protein; Cholesterol, LDL; Endothelium, Vascular; Female; Glomerul | 2011 |
High-salt diet may cause hypertension. Study suggests excessive salt use may damage blood vessels.
Topics: Biomarkers; Diet, Sodium-Restricted; Humans; Hypertension; Serum Albumin; Sodium Chloride, Dietary; | 2012 |
A role for uric acid in the progression of renal disease.
Topics: Animals; Blood Pressure; Cell Division; Cyclooxygenase 2; Disease Progression; Hypertension; Hypertr | 2002 |
A role for uric acid in the progression of renal disease.
Topics: Animals; Blood Pressure; Cell Division; Cyclooxygenase 2; Disease Progression; Hypertension; Hypertr | 2002 |
A role for uric acid in the progression of renal disease.
Topics: Animals; Blood Pressure; Cell Division; Cyclooxygenase 2; Disease Progression; Hypertension; Hypertr | 2002 |
A role for uric acid in the progression of renal disease.
Topics: Animals; Blood Pressure; Cell Division; Cyclooxygenase 2; Disease Progression; Hypertension; Hypertr | 2002 |
Metabolic influences in vascular disorders with particular reference to cholesterol determinations in comparison with uric acid levels.
Topics: Cholesterol; Humans; Peripheral Vascular Diseases; Uric Acid; Vascular Diseases | 1958 |
Treatment of arterial hypertensive disease with diuretics. II. Effects on electrolytes and uric acid of bendroflumethiazide, potassium chloride, and spironolactone.
Topics: Bendroflumethiazide; Diuretics; Electrolytes; Humans; Hypertension; Potassium Chloride; Spironolacto | 1962 |
Uric acid levels and vascular disease.
Topics: Diuretics; Greece; Humans; Hypolipidemic Agents; Risk Factors; Uric Acid; Vascular Diseases | 2004 |
Uric acid and endothelial dysfunction in essential hypertension.
Topics: Adult; Aged; Biomarkers; Comorbidity; Endothelium, Vascular; Humans; Hypertension; In Vitro Techniqu | 2006 |
Vascular risk factors and oxidative stress as independent predictors of asymptomatic atherosclerosis in adult patients with epilepsy.
Topics: Adult; Anticonvulsants; Antioxidants; Atherosclerosis; Blood Glucose; Carotid Arteries; Cholesterol; | 2007 |
Effect of bis (maltolato) oxovanadium (BMOV) in uric acid and sodium arsenite-induced vascular endothelial dysfunction in rats.
Topics: Animals; Arsenites; Endothelium, Vascular; Male; Pyrones; Rats; Rats, Wistar; Sodium Compounds; Thio | 2008 |
Hypertension and uric acid.
Topics: Humans; Hypertension; Uric Acid; Vascular Diseases | 1981 |
[Advances in the treatment of gout and hyperuricemia].
Topics: Anti-Inflammatory Agents; Female; Gout; Humans; Hypertension; Kidney Calculi; Kidney Diseases; Male; | 1981 |
[The behavior of some metabolic and instrumental parameters in diabetics with arteriopathy of the lower extremities treated with increasing doses of glucuronyl-glycosaminoglycano-sulfate].
Topics: Adult; Aged; Blood; Blood Glucose; Cholesterol; Diabetic Angiopathies; Female; Glucuronates; Glycosa | 1980 |
Common mutation in methylenetetrahydrofolate reductase. Correlation with homocysteine and other risk factors for vascular disease.
Topics: Adult; Female; Genotype; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); M | 1998 |
Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism.
Topics: Administration, Oral; Allopurinol; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Con | 2002 |
The biochemical, clinical, and genetic features of type III hyperlipoproteinemia.
Topics: Adult; Age Factors; Aged; Cholesterol; Coronary Disease; Female; Glucose Tolerance Test; Humans; Hyp | 1975 |
[Plasma fibrinogen activity in diabetes mellitus, hyperlipoproteinemia and hyperuricemia (author's transl)].
Topics: Adult; Aged; Blood Coagulation; Diabetes Mellitus; Female; Fibrinogen; Humans; Hyperlipidemias; Lipo | 1976 |
[Rehabilitation course in patients with peripheral and coronary angio-organopathies. Studies with special reference to serum uric acid and cholesterol under xanthinol nicotinate].
Topics: Adult; Cholesterol; Coronary Disease; Humans; Hypercholesterolemia; Middle Aged; Theophylline; Uric | 1977 |
Relationship of plasma uric acid to plasma lipids and lipoproteins in subjects with peripheral vascular disease.
Topics: Body Weight; Cholesterol; Coronary Disease; Female; Humans; Lipoproteins; Male; Middle Aged; Myocard | 1976 |
Hyperuricaemia--to treat or not?
Topics: Alcohol Drinking; Diet; Endocrine System Diseases; Gout; Hematologic Diseases; Humans; Hyperlipidemi | 1975 |
Major factors in the development of diabetes mellitus in 10,000 men.
Topics: Adaptation, Physiological; Adult; Africa, Northern; Age Factors; Asia; Blood Glucose; Blood Pressure | 1975 |
Clinical and metabolic study of alcoholic hyperlipidaemia.
Topics: Adult; Alcoholism; Blood Protein Disorders; Diabetes Complications; Diabetes Mellitus; Female; Human | 1972 |
Hyperuricaemia, hypertension, and vascular disease.
Topics: Humans; Hypertension; Uric Acid; Vascular Diseases | 1967 |
[Diagnosis and etiology of aseptic femoral head necrosis in adults].
Topics: Adult; Age Factors; Alcoholism; Arthritis; Bone Diseases; Cortisone; Female; Femur Head; Follow-Up S | 1970 |
Type 3 hyperlipoproteinaemia.
Topics: Adult; Apoproteins; Autopsy; Blood Glucose; Cholesterol; Chylomicrons; Dietary Carbohydrates; Electr | 1973 |
Diet, lipids and lipoproteins in patients with peripheral vascular disease.
Topics: Adult; Age Factors; Aged; Alcohol Drinking; Angiography; Arteriosclerosis; Cholesterol; Diabetes Com | 1974 |
Microangiopathy in hyperlipidemia and gout.
Topics: Adolescent; Adult; Age Factors; Aged; Basement Membrane; Biopsy, Needle; Blood Glucose; Body Weight; | 1974 |
Understanding hyperuricemia: nursing implications.
Topics: Allopurinol; Diabetes Mellitus; Diet Therapy; Gout; Humans; Kidney Diseases; Metabolic Diseases; Uri | 1972 |
Platelets and vascular disease in gout.
Topics: Allopurinol; Analgesics; Arteriosclerosis; Blood Platelets; Colchicine; Diabetes Complications; Gout | 1973 |
[Relation between hyperuricemia and dyslipemia].
Topics: Adult; Age Factors; Analysis of Variance; Blood Donors; Body Weight; Cholesterol; Female; Humans; Li | 1973 |
The diagnostic significance of the finger-tip biopsy in microangiopathies. Pathology of the arteriovenous anastomoses and preterminal circulation.
Topics: Adult; Arteriovenous Anastomosis; Biopsy; Cells, Cultured; Connective Tissue; Diabetic Angiopathies; | 1973 |
[The aetiology of myocardial infarction in young people (author's transl)].
Topics: Adult; Age Factors; Contraceptives, Oral; Female; Humans; Infections; Male; Metabolic Diseases; Myoc | 1973 |
Diabetes mellitus among 10,000 adult men. I. Five-year incidence and associated variables.
Topics: ABO Blood-Group System; Adult; Africa, Northern; Age Factors; Aged; Asia; Blood Glucose; Blood Press | 1974 |
The pregnant Natal Indian diabetic.
Topics: Adolescent; Adrenal Glands; Adult; Blood Glucose; Body Height; Body Weight; Cholesterol; Escherichia | 1969 |
["Gout" and angioorganopathies].
Topics: Arteriosclerosis Obliterans; Female; Germany, East; Gout; Humans; Male; Uric Acid; Vascular Diseases | 1971 |
Altered peritoneal permeability in patients with systemic vasculitis.
Topics: Capillary Permeability; Creatinine; Diabetic Angiopathies; Diffusion; Epithelium; Humans; Hypertensi | 1971 |
[Determination of uric acid in blood. Experimental determination; critical studies of the technics and results].
Topics: Adolescent; Adult; Aspirin; Autoanalysis; Female; Gout; Humans; Indicators and Reagents; Kidney Dise | 1971 |
[Uricemia in chronic arteriopathy of the extremities. 3. Statistical data on a continuous series of 200 personal cases. 4. Research perspectives].
Topics: Adolescent; Adult; Aged; Arteritis; Gout; Humans; Leg; Male; Middle Aged; Uric Acid; Vascular Diseas | 1969 |
[Clinical and metabolic problems in the degenerative joint disease of the diabetic].
Topics: Adult; Age Factors; Aged; Arthritis, Rheumatoid; Arthropathy, Neurogenic; Calcaneus; Calcinosis; Dia | 1970 |
Clinical survey of 354 patients with gout.
Topics: Adolescent; Adult; Age Factors; Aged; Alcohol Drinking; Blood Urea Nitrogen; Body Weight; Child; Com | 1970 |
[Results of a comparative cross section study of healthy persons and patients with circulatory disorders in longitudinal epidemiological studies].
Topics: Adult; Age Factors; Blood Sedimentation; Body Height; Body Weight; Cholesterol; Electrocardiography; | 1970 |
[Ischemic heart disease and so-called risk factors--results of an epidemiological study in Erfurt].
Topics: Angina Pectoris; Blood Glucose; Cardiovascular Diseases; Computers; Coronary Disease; Fatty Acids, E | 1971 |
Type 3 hyperlipoproteinaemia.
Topics: Adult; Arteries; Blood Protein Electrophoresis; Cholesterol; Coronary Disease; Diabetes Complication | 1969 |
[On the possible role of alimentary glucides in the genesis and evolution of isolated arteriopathies of the lower extremities].
Topics: Arteriosclerosis Obliterans; Blood Glucose; Blood Proteins; Cholesterol; Dietary Carbohydrates; Huma | 1966 |